Abstract | BACKGROUND: METHODS: For 30 or 60 days rats received daily subcutaneous injection doses of either CsA or FK-506 (10 mg/kg). The concentrations of TGF-beta1, EGF, and IL-6 in saliva were determined by enzyme-linked immunosorbent assay, and after histological processing, the oral epithelium and connective tissue were assessed at the region of the lower first molars. RESULTS: The levels of TGF-beta1, EGF, and IL-6 in saliva were not significantly altered by any of the treatments after 30 days. After 60 days of treatment with CsA, gingival overgrowth and significant increase in salivary TGF-beta1, EGF, and IL-6 concentrations were observed; no statistically significant changes were induced by FK-506. CONCLUSION:
|
Authors | Luís Carlos Spolidorio, Marinella Holzhausen, Denise M Palomari Spolidorio, Carlos A Nassar, Patricia O Nassar, Marcelo Nicolás Muscará |
Journal | Journal of periodontology
(J Periodontol)
Vol. 76
Issue 9
Pg. 1520-5
(Sep 2005)
ISSN: 0022-3492 [Print] United States |
PMID | 16171442
(Publication Type: Journal Article)
|
Chemical References |
- Cytokines
- Immunosuppressive Agents
- Interleukin-6
- Tgfb1 protein, rat
- Transforming Growth Factor beta
- Transforming Growth Factor beta1
- Epidermal Growth Factor
- Cyclosporine
- Tacrolimus
|
Topics |
- Animals
- Cyclosporine
(adverse effects)
- Cytokines
(metabolism)
- Epidermal Growth Factor
(analysis)
- Gingival Overgrowth
(chemically induced, metabolism)
- Immunosuppressive Agents
(adverse effects, pharmacology)
- Interleukin-6
(analysis)
- Male
- Rats
- Rats, Sprague-Dawley
- Saliva
(metabolism)
- Tacrolimus
(adverse effects)
- Transforming Growth Factor beta
(analysis)
- Transforming Growth Factor beta1
|